Skip to main content
Log in

Ultrasound-Guided Radiofrequency Ablation Using a New Electrode with an Electromagnetic Position Sensor for Hepatic Tumors Difficult to Place an Electrode: A Preliminary Clinical Study

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate whether a new electrode embedded with an electromagnetic position sensor (EMPS) improves the technical feasibility of percutaneous radiofrequency ablation (RFA) in patients with hepatic tumors difficult to place an electrode under ultrasonography (US) guidance and to assess short-term therapeutic efficacy and safety.

Materials and Methods

This prospective study was approved by the institutional review board, and written informed consent was obtained from all patients. Between January 2015 and December 2016, 10 patients (7 men and 3 women; age range 52–75 years) with a single hepatic tumor (median 1.4 cm; range 1.1–1.8 cm) difficult to place an electrode under US guidance were enrolled. The technical feasibility of targeting and overlapping ablation during the RFA procedure was graded using a four-point scale and analyzed using the Wilcoxon signed rank test according to the use of EMPS. In addition, the rates of technical success, local tumor progression (LTP), and major complications were assessed.

Results

The use of the new RF electrode with EMPS significantly improved the technical feasibility of targeting and overlapping ablation (p = 0.002 and p = 0.003, respectively). After treatment, the technical success rate was 100%. LTP was not found in any patient during the follow-up period (median 8 months; range 4–22 months). No major procedure-related complications occurred.

Conclusions

The technical feasibility of percutaneous RFA improves with the use of this RF electrode embedded with an EMPS. Short-term therapeutic efficacy and safety after RFA using the electrode were promising in patients with hepatic tumors difficult to place an electrode under US guidance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CT:

Computed tomography

EM:

Electromagnetic

EMPS:

Electromagnetic position sensor

HCC:

Hepatocellular carcinoma

LTP:

Local tumor progression

MRI:

Magnetic resonance imaging

RFA:

Radiofrequency ablation

References

  1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–55.

    Article  PubMed  Google Scholar 

  2. Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes—a 10-year experience at a single center. Radiology. 2016;278(2):601–11.

    Article  PubMed  Google Scholar 

  3. Lee MW. Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography. 2014;33(4):227–39.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kim J, Yoon CJ, Seong NJ, Jeong SH, Kim JW. Fluoroscopy-guided radiofrequency ablation for small hepatocellular carcinoma: a retrospective comparison with ultrasound-guided ablation. Clin Radiol. 2015;70(9):1009–15.

    Article  CAS  PubMed  Google Scholar 

  5. Rempp H, Unterberg J, Hoffmann R, et al. Therapy monitoring of magnetic resonance-guided radiofrequency ablation using T1- and T2-weighted sequences at 1.5 T: reliability of estimated ablation zones. Invest Radiol. 2013;48(6):429–36.

    Article  PubMed  Google Scholar 

  6. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–71.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol. 2010;195(3):758–65.

    Article  PubMed  Google Scholar 

  8. Minami Y, Chung H, Kudo M, et al. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol. 2008;190(6):W335–41.

    Article  PubMed  Google Scholar 

  9. Song KD, Lee MW, Rhim H, Cha DI, Chong Y, Lim HK. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound. AJR Am J Roentgenol. 2013;201(5):1141–7.

    Article  PubMed  Google Scholar 

  10. Appelbaum L, Mahgerefteh SY, Sosna J, Goldberg SN. Image-guided fusion and navigation: applications in tumor ablation. Tech Vasc Interv Radiol. 2013;16(4):287–95.

    Article  PubMed  Google Scholar 

  11. Min JH, Lim HK, Lim S, et al. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. Clin Mol Hepatol. 2014;20(1):61–70.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hakime A, Deschamps F, De Carvalho EG, Barah A, Auperin A, De Baere T. Electromagnetic-tracked biopsy under ultrasound guidance: preliminary results. Cardiovasc Interv Radiol. 2012;35(4):898–905.

    Article  Google Scholar 

  13. Jung EM, Friedrich C, Hoffstetter P, et al. Volume navigation with contrast enhanced ultrasound and image fusion for percutaneous interventions: first results. PLoS ONE. 2012;7(3):e33956.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Tomonari A, Tsuji K, Yamazaki H, et al. Feasibility of the virtual needle tracking system for percutaneous radiofrequency ablation of hepatocellular carcinoma. Hepatol Res. 2013;43(12):1352–5.

    Article  PubMed  Google Scholar 

  15. Kang TW, Lee MW, Choi SH, et al. A novel electrode with electromagnetic tip tracking in ultrasonography-guided radiofrequency ablation: a phantom, ex vivo, and in vivo experimental study. Invest Radiol. 2015;50(2):81–7.

    Article  PubMed  Google Scholar 

  16. Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology. 2014;273(1):241–60.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Rhim H, Choi D, Kim YS, Lim HK, Choe BK. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol. 2010;75(2):253–8.

    Article  PubMed  Google Scholar 

  18. Lee MW, Rhim H, Cha DI, Kim YJ, Lim HK. Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas (1–3 cm): value of fusion imaging with conventional US and CT/MR images. J Vasc Interv Radiol. 2013;24(7):958–65.

    Article  PubMed  Google Scholar 

  19. Kang TW, Lim HK, Lee MW, et al. Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study. Radiology. 2016;280(1):300–12.

    Article  PubMed  Google Scholar 

  20. Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. Radiology. 2014;270(3):888–99.

    Article  PubMed  Google Scholar 

  21. Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H. First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up. Clin Radiol. 2013;68(12):e641–51.

    Article  CAS  PubMed  Google Scholar 

  22. Venkatesan AM, Kadoury S, Abi-Jaoudeh N, et al. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation. Radiology. 2011;260(3):848–56.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Krucker J, Xu S, Venkatesan A, et al. Clinical utility of real-time fusion guidance for biopsy and ablation. J Vasc Interv Radiol. 2011;22(4):515–24.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol. 2007;188(2):480–8.

    Article  PubMed  Google Scholar 

  25. Hakime A, Barah A, Deschamps F, et al. Prospective comparison of freehand and electromagnetic needle tracking for US-guided percutaneous liver biopsy. J Vasc Interv Radiol. 2013;24(11):1682–9.

    Article  PubMed  Google Scholar 

  26. Dodd GD 3rd, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol. 2001;177(4):777–82.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Mr. Joon Hyok Lee (STARmed, Goyang, South Korea) for his technical assistance.

Financial Support

Financial support and the investigational RF ablation device for this study were provided by STARmed (Goyang, Korea). However, the authors had complete control of the data and information submitted for publication, which was unbiased by the industry.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Min Woo Lee.

Ethics declarations

Conflict of interest

The authors do not have any conflicts of interest to declare.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (WMV 7289 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, T.W., Lee, M.W., Song, K.D. et al. Ultrasound-Guided Radiofrequency Ablation Using a New Electrode with an Electromagnetic Position Sensor for Hepatic Tumors Difficult to Place an Electrode: A Preliminary Clinical Study. Cardiovasc Intervent Radiol 40, 1891–1898 (2017). https://doi.org/10.1007/s00270-017-1751-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-017-1751-9

Keywords

Navigation